Haitham Habashi, general manager for Merck Saudi Arabia, outlines his affiliate’s approach to the big reforms shaping the country’s healthcare system, discusses the new public procurement process, and explains why Vision 2030 means transformative opportunities for Saudis, women, and health. Moreover, he highlights Merck’s manufacturing in Saudi Arabia and its work on clinical research and development.
We have leading products in diabetes, cardio, and fertility, neurology and are also very strong in oncology. It is not only about being number one in size, but also about the culture, our reputation, and how can we serve patients
